The establishment of Big Data Centre in Emergency Medicine represents a significant advancement in utilizing electronic health records for clinical insights. This initiative could reshape treatment protocols and resource allocation, making it crucial for pharma strategy teams to stay informed on its developments. Regulatory context from MHRA (Clinical trials for medicines: modifying a clinical trial approval) supports the near-term read. Assessment grounded in 24 ranked evidence items (20 high-relevance).